메뉴 건너뛰기




Volumn 89, Issue 4, 2011, Pages 554-561

Global requirements for dna sample collections: Results of a survey of 204 ethics committees in 40 countries

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DNA DETERMINATION; DNA SCREENING; GENETIC ANALYSIS; HUMAN; MEDICAL RESEARCH; ORGANIZATION AND MANAGEMENT; PHARMACOGENETICS; PRIORITY JOURNAL; QUESTIONNAIRE; UNITED STATES;

EID: 79952993467     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2010.319     Document Type: Article
Times cited : (19)

References (20)
  • 2
    • 40049095337 scopus 로고    scopus 로고
    • A proposal for a model of informed consent for the collection, Storage and use of biological materials for research purposes
    • Porteri, C. & Borry, P. A proposal for a model of informed consent for the collection, Storage and use of biological materials for research purposes. Patient Educ. Couns. 71, 136-142 (2008).
    • (2008) Patient Educ. Couns. , vol.71 , pp. 136-142
    • Porteri, C.1    Borry, P.2
  • 3
    • 28644448646 scopus 로고    scopus 로고
    • Terminology for sample collection in clinical genetic studies
    • pharmacogenetics Working Group
    • Spear, B.B. et al.; pharmacogenetics Working Group. Terminology for sample collection in clinical genetic studies. Pharmacogenomics J. 1, 101-103 (2001)
    • (2001) Pharmacogenomics J. , vol.1 , pp. 101-103
    • Spear, B.B.1
  • 5
    • 79952984875 scopus 로고    scopus 로고
    • Challenges in conducting clinical research trials in emerging market economies
    • Roohi, F.H. Challenges in conducting clinical research trials in emerging market economies. Monitor 23, 31-35 (2009).
    • (2009) Monitor , vol.23 , pp. 31-35
    • Roohi, F.H.1
  • 6
    • 79952989340 scopus 로고    scopus 로고
    • Successful start of clinical trials in israel: A roadmap for pharmaceutical and medical device trials
    • Koren, A. Successful start of clinical trials in israel: a roadmap for pharmaceutical and medical device trials. Monitor 21, 57-61 (2007).
    • (2007) Monitor , vol.21 , pp. 57-61
    • Koren, A.1
  • 7
    • 79952991774 scopus 로고    scopus 로고
    • The current regulatory environment for clinical research in india
    • Gupta, S.K. The current regulatory environment for clinical research in india. Monitor 23, 27-29 (2009).
    • (2009) Monitor , vol.23 , pp. 27-29
    • Gupta, S.K.1
  • 9
    • 79952984928 scopus 로고    scopus 로고
    • International clinical trials in Russia: An insider's perspective
    • Storozhuk, E., Khabriev, R.U. & Filunin, S.V. International clinical trials in Russia: an insider's perspective. Monitor 21, 35-39 (2007).
    • (2007) Monitor , vol.21 , pp. 35-39
    • Storozhuk, E.1    Khabriev, R.U.2    Filunin, S.V.3
  • 10
    • 33646254125 scopus 로고    scopus 로고
    • Reporting genetic results in research studies: Summary and recommendations of an NHLBi working group
    • NHLBi Working Group
    • Bookman, E.B. et al.; NHLBi Working Group. Reporting genetic results in research studies: summary and recommendations of an NHLBi working group. Am. J. Med. Genet. A 140, 1033-1040 (2006).
    • (2006) Am. J. Med. Genet. A , vol.140 , pp. 1033-1040
    • Bookman, E.B.1
  • 12
    • 79952994279 scopus 로고    scopus 로고
    • Coding of DNa samples and data in the pharmaceutical industry: Current practices and future directions
    • Franc, M.A., Cohen, N., Warner, A.W., Shaw, P.M., Groenen, P. & Snapir, A. Coding of DNa samples and data in the pharmaceutical industry: current practices and future directions. Clin. Pharm. Ther. 89, 537-545 (2011).
    • (2011) Clin. Pharm. Ther. , vol.89 , pp. 537-545
    • Franc, M.A.1    Cohen, N.2    Warner, A.W.3    Shaw, P.M.4    Groenen, P.5    Snapir, A.6
  • 14
    • 79952991837 scopus 로고    scopus 로고
    • Challenges in obtaining adequate genetic sample sets in clinical trials: The perspective of the industry pharmacogenomics Working Group
    • Warner, A.W. et al. Challenges in obtaining adequate genetic sample sets in clinical trials: the perspective of the industry pharmacogenomics Working Group. Clin. Pharm. Ther. 89, 529-536 (2011).
    • (2011) Clin. Pharm. Ther. , vol.89 , pp. 529-536
    • Warner, A.W.1
  • 17
    • 79952993123 scopus 로고    scopus 로고
    • Current practices for DNa sample collection and storage in the pharmaceutical industry, and potential areas for harmonization
    • Franc, M.A., Warner, A.W., Cohen, N., Shaw, P.M., Groenen, P. & Snapir, A. Current practices for DNa sample collection and storage in the pharmaceutical industry, And potential areas for harmonization. Clin. Pharm. Ther. 89, 546-553 (2011).
    • (2011) Clin. Pharm. Ther. , vol.89 , pp. 546-553
    • Franc, M.A.1    Warner, A.W.2    Cohen, N.3    Shaw, P.M.4    Groenen, P.5    Snapir, A.6
  • 18
    • 80052667893 scopus 로고    scopus 로고
    • US Food and Drug administration
    • US Food and Drug administration. Meeting of advisory Committee for pharmaceutical Science and Clinical pharmacology. http://www.Fda.Gov/downloads/ advisoryCommittees/CommitteesMeetingMaterials/Drugs/ advisoryCommitteeforpharmaceuticalScienceandClinicalpharmacology/ UCM210803.Pdf (2010).
    • (2010) Meeting of Advisory Committee for Pharmaceutical Science and Clinical Pharmacology
  • 19
    • 79951480123 scopus 로고    scopus 로고
    • R Development Core Team R Foundation for Statistical Computing Vienna Austria
    • R Development Core Team. R: a Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria http://www.R-project.Org/ (2010).
    • (2010) R: A Language and Environment for Statistical Computing


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.